ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0946

Tissue Resident Monocyte-lineage Cells (TR-MC) Exist as Two Different Subpopulations

Yidan Wang1, Jessica Maciuch2, Tyler Therron3, Carla Cuda2, Deborah Winter4 and Harris Perlman2, 1Northwestern University, Hanover Park, IL, 2Northwestern University, Chicago, IL, 3Northwestern University, Chicago, 4Northwestern University, Skokie, IL

Meeting: ACR Convergence 2024

Keywords: Genomics and Proteomics, Monocytes/macrophages, Mouse Models, RA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Monocytes are critical for the pathogenesis of rheumatoid arthritis (RA). However, depletion of peripheral monocytes (PM) is not sufficient to rescue disease in RA mouse models. Recently, we identified a novel extravascular cell type, namely tissue-resident monocyte lineage cells (TR-MC) which are distinct from macrophages and PM. Equivalent TR-MC have been identified in human synovium, therefore, investigating TR-MC will provide insight on developing cell therapy for RA. TR-MC in mice are sensitive to clodronate liposomes (clo-lip) and are required for the development of acute RA-like disease in mouse. Nevertheless, the ontogeny of TR-MC and the dynamics of TR-MC during inflammation remained unclear. 

Methods: Ccr2-/-, Nr4a1-se2-def, Lyve1-GFP/+, Ccr2 GFP/+, CD45.1 and wild-type C57BL/6 mice were used in this study. CD45.1  CD45.2 bone marrow chimera (BMC) mice were generated with ankle shielding. CD45.1 & CD45.2 parabiosis mice were generated. Clo-lip was administered to BMC mice to deplete TR-MC and cell numbers were measured via flow cytometry. Serum transfer-induced arthritis (STIA) was initiated on BMC mice. Cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) was performed on synovial CD45+CD11b+Ly6G−SiglecF−CD4-CD8-NK1.1-CD19-CD64−MHCII-CD177- cells from steady-state BMC, day 7 clo-lip BMC, and day 7, 14, 56 STIA BMC mice.

Results: To determine the dependence of TR-MC on PM, we compared the number of TR-MC in CM-depleted (Ccr2-/-), NCM-depleted (Nr4a1-se2-def), and control mice. The results showed that TR-MC were significantly reduced in CM-depleted mice but remained comparable in NCM-depleted, suggesting a subpopulation of TR-MCs is dependent on Ccr2. Similarly, we identified a consistent subpopulation of CD45.1 donor-derived TR-MC in steady-state BMC mice demonstrating that a portion of TR-MC are bone marrow derived, while the remainder were CD45.2 long-lived recipient cells. TR-MC subpopulations have also been identified using parabiosis mice. CITE-seq results of steady-state BMC showed that BM-derived and long-lived TR-MC could be distinguished by RNA expression of Ccr2 and Lyve1, respectively. These results were confirmed using Lyve1-GFP/+ and Ccr2 GFP/+ mice. GO results showed that long-lived TR-MC were enriched in homeostasis maintenance pathways, whereas BM-derived TR-MC showed enrichment in adaptive immunity associated processes. When treated with clo-lip, long-lived TR-MC were partially depleted, while the numbers of BM-derived TR-MC were not significantly changed. CITE-seq results during STIA time course showed a gradual increase in BM-derived TR-MC relative to long-lived TR-MC during the development of arthritis. During recovery, the populations returned to relatively equal numbers.

Conclusion: Our study revealed two distinct populations of TR-MC: 1) long-lived TR-MC, which are sensitive to clo-lip and are outnumbered by 2) BM-derived CCR2-dependent TR-MC during STIA development. BM-derived TR-MC serve to connect innate and adaptive immune responses, whereas long-lived TR-MC are involved in maintaining synovial tissue homeostasis. The findings above about the subpopulations of TR-MC will help develop treatments for RA. 


Disclosures: Y. Wang: None; J. Maciuch: None; T. Therron: None; C. Cuda: None; D. Winter: None; H. Perlman: Abbvie, 2, AnaptysBio, 12, Speaking, advising, consulting, or providing educational programs, Exagen, 2, Janssen, 2, Kiniksa, 2.

To cite this abstract in AMA style:

Wang Y, Maciuch J, Therron T, Cuda C, Winter D, Perlman H. Tissue Resident Monocyte-lineage Cells (TR-MC) Exist as Two Different Subpopulations [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/tissue-resident-monocyte-lineage-cells-tr-mc-exist-as-two-different-subpopulations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tissue-resident-monocyte-lineage-cells-tr-mc-exist-as-two-different-subpopulations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology